Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hodgkin Disease 12Lymphoma 10Testicular Neoplasms 2Teratoma 2Endodermal Sinus Tumor 2Testicular Germ Cell Tumor 1Sertoli-Leydig Cell Tumor 1Recurrence 1Ovarian gynandroblastoma 1Ovarian Germ Cell Cancer 1Lymphoma, Follicular 1HIV Infections 1Granulosa cell tumor of the ovary 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Embryonal 1Breast Neoplasms 1

Interventions

Paclitaxel 2etoposide phosphate 1Taxes 1Platinum 1Immunoglobulin G 1Disulfides 1Cisplatin 1Carboplatin 1Bleomycin 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sertoli-Leydig Cell Tumor × Bleomycin × Clear all
NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

GOG Foundation

Phase 2 Unknown
63 enrolled 16 charts
Gynecologic

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡